Skip to search.
 All Ordinaries Down 0.21%

More On VLA.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Viralytics Ltd (VLA.AX)

-ASX
0.86 Down 0.06(6.56%) 11:34
Prev Close:0.92
Open:0.92
Bid:0.86
Ask:0.86
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.86 - 0.92
52wk Range:0.52 - 1.12
Volume:176,603
Avg Vol (3m):217,613
Market Cap:205.45M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Viralytics Limited, a biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies in Australia. Its lead investigational product is CAVATAK, a proprietary formulation of an oncolytic common cold virus that ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback